Pharmacogenomics, ancestry and clinical decision making for global populations
about
Progress in understanding the genomic basis for adverse drug reactions: a comprehensive review and focus on the role of ethnicityExploring the distribution of genetic markers of pharmacogenomics relevance in Brazilian and Mexican populationsA European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical PharmacogenomicsGenetic diversity of variants involved in drug response and metabolism in Sri Lankan populations: implications for clinical implementation of pharmacogenomicsWhat does genomic medicine mean for diverse populations?Genomic data-sharing: what will be our legacy?Genetic epidemiology: the potential benefits and challenges of using genetic information to improve human health.Large-scale pharmacogenomic study of sulfonylureas and the QT, JT and QRS intervals: CHARGE Pharmacogenomics Working Group.Clinical and pharmacogenomic implications of genetic variation in a Southern Ethiopian population.Translational Genomics in Low- and Middle-Income Countries: Opportunities and Challenges.Genetic epidemiology of type 2 diabetes and cardiovascular diseases in Africa.Characterization of ADME gene variation in 21 populations by exome sequencing.Genome science and health disparities: a growing success story?Pharmacogenomic implications of the evolutionary history of infectious diseases in AfricaExploring public genomics data for population pharmacogenomicsPharmacogenomics study of thiazide diuretics and QT interval in multi-ethnic populations: the cohorts for heart and aging research in genomic epidemiology.The global spectrum of protein-coding pharmacogenomic diversity.Landscape of warfarin and clopidogrel pharmacogenetic variants in Qatari population from whole exome datasets.Association of Genetic Polymorphisms in the VKORC1 and CYP2C9 Genes with Warfarin Dosage in a Group of Kuwaiti Individuals.Genetic epidemiology of pharmacogenetic variants in South East Asian Malays using whole-genome sequences.Analysis of population-specific pharmacogenomic variants using next-generation sequencing data.The genomic landscape of African populations in health and disease.Genetic variation in human drug-related genes.Genetic architectures of ADME genes in five Eurasian admixed populations and implications for drug safety and efficacy.Interethnic DNA methylation difference and its implications in pharmacoepigenetics.Health regulatory communications of well-established safety-related pharmacogenomics associations in six developed countries: an evaluation of alignment.History repeats itself: the family medication history and pharmacogenomics.The need for an integrated approach for chronic disease research and care in Africa.
P2860
Q28083100-3E2A0AAC-F78C-4A2A-8E95-CF469433C388Q28545128-34563F00-94B2-41C7-8207-0574BC7C0ACEQ28554199-DDE07BAA-087E-4A92-AFE8-7940378EEF97Q28601852-467214E8-834C-42AA-8130-7A0D345E68A6Q28659678-711E21F8-1A36-4FDD-9719-2C8030BABFE7Q30779143-D96C3934-06C3-4153-AD8B-EC32C0727641Q33698750-7B0D2B5C-8BBA-4328-B228-B1CADD0DC509Q33790423-775B9546-D0A3-4D56-867C-818DDE77A797Q34778035-FE5EEBED-DD2E-4020-BD83-918DD8B44AE8Q35888017-1AFD3ADC-E886-4297-8AD8-EE59875A0963Q37342581-FC0D1621-DFBF-4EBC-8D5A-3D765AD79415Q37619264-D6E271E3-549D-4889-AB67-13CEB61EDADFQ37690918-801B135C-2000-45A4-AC47-926B51DF86A2Q37737731-C8514FDE-8192-4094-86E4-FD832F6EB84EQ38644432-EC970BA3-328E-409A-BA06-6818BBFC1919Q38655838-FEC99650-81D1-4176-BD9F-8FC6CA4D4433Q38806047-8D5FB893-A3C3-49A9-8A1C-E7064B048F33Q39262868-E34E180A-0F6A-4471-A96F-53AC8E8321B4Q39950111-476E4647-2AC1-4F6A-BB4C-13680D640A19Q40728342-3317773F-E52E-43B5-B3F2-5A6DB3441460Q41606948-91183A7B-3E92-4DDE-BD33-23C1881A73DEQ41924616-883F3873-BB9C-4059-9AB7-228B1E8A4655Q47564586-B842EA24-6B1C-4F21-89C1-852CAE7F1780Q47619441-E388FDB7-5BD7-40A8-B6EF-045957674D56Q47960568-9DA5F5EE-1D1A-40D5-93B4-1F9B6E118FAAQ48861311-7099DB72-341F-4C63-A84D-7CEA7286D184Q50856364-446ECC2A-D5D8-4302-B746-3B3155D7008BQ55054487-FA136AB3-E062-43AB-A074-E97A92BC1B84
P2860
Pharmacogenomics, ancestry and clinical decision making for global populations
description
im Juli 2013 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в липні 2013
@uk
name
Pharmacogenomics, ancestry and clinical decision making for global populations
@en
Pharmacogenomics, ancestry and clinical decision making for global populations
@nl
type
label
Pharmacogenomics, ancestry and clinical decision making for global populations
@en
Pharmacogenomics, ancestry and clinical decision making for global populations
@nl
prefLabel
Pharmacogenomics, ancestry and clinical decision making for global populations
@en
Pharmacogenomics, ancestry and clinical decision making for global populations
@nl
P2093
P2860
P356
P1476
Pharmacogenomics, ancestry and clinical decision making for global populations
@en
P2093
A Doumatey
A G Elkahloun
C N Rotimi
P2860
P2888
P304
P356
10.1038/TPJ.2013.24
P577
2013-07-09T00:00:00Z